Pharmaforte Singapore Pte Ltd is a distributor of pharmaceuticals, including ethical, over-the-counter (OTC), medical disposables, diagnostics, and dental products. It has been in operation since 1995 and is involved in the health care, pharmaceutical, and marketing industries. The company acts as a distributor for several international healthcare companies from various countries, including Canada, Germany, Italy, Korea, and the USA. Pharmaforte received a Private Equity Round investment on 15 January 2021, with the investment coming from Advantage Partners. This investment is a testament to the company's potential for growth and its ability to attract interest from prominent investors. It also indicates a recognition of the value and relevance of Pharmaforte's position within the pharmaceutical distribution industry. This investment provides the company with the means to further its distribution efforts and potentially expand its reach within the market. Pharmaforte's role in distributing pharmaceuticals and healthcare products positions it at the intersection of crucial industries, addressing the growing global demand for reliable and efficient distribution channels in the healthcare sector. With its established history and international partnerships, the company holds the potential to leverage its experience and network to further solidify its position in the market and potentially explore innovative strategies for growth and expansion.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
15 Jan 2021 |
No recent news or press coverage available for Pharmaforte Singapore Pte Ltd.
We care about your data, and we'd love to use cookies make your experience better.
